Preliminary Study Examining Heart Failure Patients Responses to Depression Education

NCT ID: NCT01794598

Last Updated: 2014-09-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

270 participants

Study Classification

INTERVENTIONAL

Study Start Date

2004-05-31

Study Completion Date

2006-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Purpose of the Study: The significant impact of depression on the poor prognosis and functional restrain, recognition and successful treatment of depression in patients with Chronic Heart Failure (CHF) may result in improvement of overall outcome of those patients. However, depression comorbid with CHF has been overlooked in the real practice. Therefore, the investigators are proposing a study to 1) assess the prognostic impact of depression in patients with stable CHF who have been managed as outpatients, and 2) assess whether provision of depression education to CHF patients will improve the care of depression.

Patients with chronic heart failure are enrolled into this study with a half of them are randomly assigned to receive a packet of depression education materials and then other half not. Participants and investigators both are blinded to the assignment. All the participants are provided a toll free phone number to contact the research team as needed. Depressive symptoms and patients knowledge of depression are assessed at baseline prior to randomization and at 1-month and 6-month following the enrollment.

Responses of the study participants, such as change of depressive symptoms, and requests for psychiatric help are examined between two groups.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Heart Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Educational materials

Receiving educational materials of depression care

Group Type EXPERIMENTAL

Receiving educational material of depression care

Intervention Type BEHAVIORAL

The educational material provides patients about depression management

No educational materials

Receiving an envelope but no inclusion of educational materials of depression care

Group Type SHAM_COMPARATOR

Receiving educational material of depression care

Intervention Type BEHAVIORAL

The educational material provides patients about depression management

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Receiving educational material of depression care

The educational material provides patients about depression management

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* LVEF ≤ 35%.
* NYHA class II, III, or IV heart failure for the previous three months despite a minimum of 6 weeks of treatment.
* Must be on optimal heart failure therapy according to AHA/ACC and HFSA heart failure guidelines, including treatment with ACEI and beta-blocker therapy, or have documented rationale for variation, including intolerance, contraindication, patient preference, or personal physician's judgment.

Exclusion Criteria

* Age less than 18.
* Currently pregnant or intending to become pregnant in the next year.
* Cardiovascular procedure or hospitalization for any reason planned in the next 6 months.
* Expectation of receiving a cardiac transplant in the next six months.
* Unable to provide the study consent.
* Participation another clinical trial(s) that may interfere with follow-up or data collection for this study, or that may affect cardiovascular mortality.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Duke University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Wei Jiang, MD

Role: PRINCIPAL_INVESTIGATOR

Duke University

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

5132-03-8R0ER

Identifier Type: OTHER

Identifier Source: secondary_id

5132

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Heart Failure Medication Adherence
NCT03402750 COMPLETED NA
Decision Support for Heart Failure Prescribing
NCT06293794 ACTIVE_NOT_RECRUITING NA
Psychosocial Syndemics of Heart Failure
NCT04637776 ACTIVE_NOT_RECRUITING